The Latest Developments in Insulin Injection Devices

The Diabetes Educator

Volumn 26, Issue 1, 2000, Pages 135-152

  Robertson, Kenneth E ^a   Glazer, N Bradley ^a   Campbell, R Keith ^b  

^a ELI LILLY AND COMPANY   (United States)

^b WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; INSULIN;

EQUIPMENT; EQUIPMENT DESIGN; FORECASTING; HUMAN; INFUSION PUMP; INSTRUMENTATION; JET INJECTION; REVIEW; SUBCUTANEOUS DRUG ADMINISTRATION; SYRINGE; UNITED STATES;

EQUIPMENT DESIGN; EQUIPMENT FAILURE; FORECASTING; HUMANS; HYPOGLYCEMIC AGENTS; INFUSION PUMPS; INJECTIONS, JET; INJECTIONS, SUBCUTANEOUS; INSULIN; SYRINGES; UNITED STATES;

EID: 0033641042     PISSN: 01457217     EISSN: None     Source Type: Journal    
DOI: 10.1177/014572170002600114     Document Type: Article

References (40)

1. Banting FG, Best CH. The internal secretion of the pancreas. J Lab Clin Med. 1922;7:251-266.
2. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of longterm complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977-986.
3. DCCT: What it means to you [special report]. Diabetes Forecast. 1993:6-6.
4. Ohkubo Y, Kishikawa H, Araki E, et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract. 1958;28:103-117.
5. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837-853.
6. Krall LP, Beaser RS. Joslin Diabetes Manual. 12th ed. Philadelphia: Lea & Febiger; 1989.
7. Coonrod BA. Insulin syringes and pens: finding the best match for your patients’ needs. Clin Diabetes. 1997;May/June:114-120.
8. MacCracken J, Stenger P, Jackson T. Latex allergy in diabetic patients: a call for latex-free insulin tops [letter]. Diabetes Care. 1996;19:184-184.
9. Gnanalingham MG, Newland P, Smith CP. Accuracy and reproducibility of low dose insulin administration using pen injectors and syringes. Arch Dis Child. 1998;79:59-62.
10. Lteif AN, Schwenk WF. Accuracy of pen injectors versus insulin syringes in children with type 1 diabetes. Diabetes Care. 1999; 22:137-140.
11. Coscelli C, Calabrese G, Fedele D, et al. Use of premixed insulin among the elderly: reduction of errors in patient preparation of mixtures. Diabetes Care. 1992;15:1628-1630.
12. Unger J. Principles of intensive insulin therapy. Hosp Physician. 1994;18: 8-20.
13. Bode B. Getting the best management from my insulin pump [letter]. Diabetes Interview. 1999;8:35-35.
14. Melki V, Renard E, Lassmann-Vague V, et al. Improvement of HbA1c and blood glucose stability in IDDM patients treated with lispro insulin analog in external pumps. Diabetes Care. 1998:977-982.
15. Williams AS. Teaching nonvisual diabetes self care: choosing appropriate tools and techniques for visually impaired individuals. Diabetes Spectrum. 1997; 10:128-134.
16. Henrichs HR, Unger H, Trautmann ME, Pfutzner A. Severe insulin resistance treated with insulin lispro [letter]. Lancet. 1996;348: 1248-1248.
17. Walsh J, Roberts R. Pumping Insulin: Advantages and Disadvantages. In: Pumping Insulin. 2nd ed. San Diego, Calif: Torrey Pines Press; 1994.
18. American Diabetes Association. Position statement. Insulin administration. Diabetes Care. 1997; 20(suppl 1):S46-S49.
19. Tallroth G, Karlson B, Nilsson A, Agardh CD. The influence of different insulin regimens on quality of life and metabolic control in insulin-dependent diabetics. Diabetes Res Clin Pract. 1989;6:37-43.
20. Phoenix International Research. Data on file. Indianapolis, Ind: Eli Lilly and Co; 1996.
21. Eastman RC, et al. What you can do to lessen the burden of diabetes for your patients. Resident Staff Physician. 1994;40:15-15.
22. Loewenstein JE. Insulin pumps and other recent advances in the outpatient treatment of diabetes. Ann Intern Med. 1984;144: 755-758.
23. Bouchard M, Chatelain P. Insulin pens and cartridges containing prepared mixtures for “personalized” insulin therapy in diabetic infants and adolescents [abstract]. Horm Res. 1996;46(suppl 2):56-56. Abstract A219.
24. Okada S. Treatment of type I diabetes using a penstyle delivery system and a preparation combining shortand intermediateacting insulin. J Int Med Res. 1993;21:216-223.
25. McCaughey ES, Betts PR, Rowe DJ. Improved diabetic control in adolescents using the penject syringe for multiple insulin injections. Diabetic Med. 1986;3:234-236.
26. Davies RR, McEwen J, Moreland TA, Durnin C, Newton RW. Improvement in morning hyperglycemia with basal human ultratard and prandial human actrapid insulin-a comparison of multiple injection regimens. Diabetic Med. 1988;5:671-675.
27. Jefferson IG, Marteau TM, Smith MA, Baum JD. A multiple injection regimen using an insulin injection pen and prefilled cartridges of soluble human insulin in adolescents with diabetes. Diabetic Med. 1985;2: 493-495.
28. Jorgensen JOL, Flyvbjers A, Jorgensen JJ. NPH insulin administered by means of a pen injection. Diabetic Med. 1988;5: 574-576.
29. Kolendorf K, BeckBielsen H, Oxenboll B. Clinical experience with NovoPen II and insulin protophane penfill. Postgrad Med J. 1988; 64(suppl 3):14-16.
30. Homquist JO, Wikby A, Stenstrom U, Andersson PO. Change in quality of life along with type I diabetes. Diabetes Res Clin Pract. 1995;28:63-72.
31. Coscelli C, Lostia S, Lunetta M, Nosari I, Coronel GA. Safety, efficacy, acceptability of a pre-filled insulin pen in diabetic patients over 60 years old. Diabetes Res Clin Pract. 1995;28:173-177.
32. Corcoran JS, Yudkin JS. A comparison of premixed with patient-premixed insulins. Diabetic Med. 1986;3:246-249.
33. Dunbar JM, Madden PM, Gleeson DT, Fiad TM, McKenna TJ. Premixed insulin preparations in pen syringes maintain glycemic control and are preferred by patients. Diabetes Care. 1994;17:874-878.
34. O’Hagan M, Greene SA. Pre-mixed insulin delivered by disposable pen in the management of children with diabetes. Diabetic Med. 1993;10:972-975.
35. Ginsberg BH, Parkes JL, Sparacino C. The kinetics of insulin administration by insulin pens. Horm Metab Res. 1994;26: 584-587.
36. Chantelau E, Heinemann L, Ross D. Air bubbles in insulin pens. Lancet. 1989;i:387-388.
37. Kristensen JS. Comment. Horm Metab Res. 1995;27:513-513.
38. Selam JL, Micossi P, Dunn FL, Nathan DM. Clinical trial of programmable implantable insulin pump for type I diabetes. Diabetes Care. 1992;15:877-885.
39. Chien YW, Siddiqui O, Sun Y, Shi WM, Liu JC. Transdermal iontophoretic delivery of therapeutic peptides/proteins. I. Insulin. Proc Natl Acad Sci U S A. 1987;507:32-51.
40. Galloway JA, Chance RE. Improving insulin therapy: achievements and challenges. Horm Metab Res. 1994;26:591-598.